Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis

Por Atassi, Nazem, Cudkowicz, Merit E., Schoenfeld, David A.
Publicado em 2011

Causal inference methods to study gastric tube use in amyotrophic lateral sclerosis

Por McDonnell, Erin, Schoenfeld, David, Paganoni, Sabrina, Atassi, Nazem
Publicado no Neurology (2017)

Disease burden in upper motor neuron syndromes: a survey of patient perspectives

Por Andrews, JA, Paganoni, Sabrina, Braastad, Corey, Cudkowicz, Merit, Atassi, Nazem
Publicado no J Clin Neuromuscul Dis (2014)

Depression in amyotrophic lateral sclerosis

Por ATASSI, NAZEM, COOK, AMANDA, PINEDA, CRISTIANA M. E., YERRAMILLI-RAO, PADMAJA, PULLEY, DARLENE, CUDKOWICZ, MERIT
Publicado em 2010

ALS Biomarkers for Therapy Development: State of the Field & Future Directions

Por Benatar, Michael, Boylan, Kevin, Jeromin, Andreas, Rutkove, Seward B., Berry, James, Atassi, Nazem, Bruijn, Lucie
Publicado no Muscle Nerve (2015)

Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)

Por PAGANONI, SABRINA, MACKLIN, ERIC A., LEE, ALEXANDRA, MURPHY, ALYSSA, CHANG, JUDITH, ZIPF, AMANDA, CUDKOWICZ, MERIT, ATASSI, NAZEM
Publicado no Amyotroph Lateral Scler Frontotemporal Degener (2014)

Feedback interaction of research, advocacy, and clinical care applied to ALS research in South America

Por Bucheli, Miriam E., Calderón, Amelia, Chicaiza, Diana, Franco, Carolina, López, Ricardo, Digga, Elise, Atassi, Nazem, Salameh, Johnny, Berry, James D.
Publicado em 2013

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheim...

Por Delnomdedieu, Marielle, Duvvuri, Sridhar, Li, David Jianjun, Atassi, Nazem, Lu, Ming, Brashear, H. Robert, Liu, Enchi, Ness, Seth, Kupiec, James W.
Publicado no Alzheimers Res Ther (2016)

A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis

Por ATASSI, NAZEM, RATAI, EVA-MARIA, GREENBLATT, DAVID J., PULLEY, DARLENE, ZHAO, YANLI, BOMBARDIER, JEFFERY, WALLACE, STUART, ECKENRODE, JOANNA, CUDKOWICZ, MERIT, DIBERNARDO, ALLITIA
Publicado em 2010

The PRO-ACT database: Design, initial analyses, and predictive features

Por Atassi, Nazem, Berry, James, Shui, Amy, Zach, Neta, Sherman, Alexander, Sinani, Ervin, Walker, Jason, Katsovskiy, Igor, Schoenfeld, David, Cudkowicz, Merit, Leitner, Melanie
Publicado no Neurology (2014)

Functional Decline is Associated with Hopelessness in Amyotrophic Lateral Sclerosis (ALS)

Por Paganoni, Sabrina, McDonnell, Erin, Schoenfeld, David, Yu, Hong, Deng, Jing, Atassi, Hamza, Sherman, Alexander, Yerramilli-Rao, Padmaja, Cudkowicz, Merit, Atassi, Nazem
Publicado no J Neurol Neurophysiol (2017)

Analysis of participant withdrawal in Huntington disease clinical trials

Por Banno, Haruhiko, Andrzejewski, Kelly L., McDermott, Michael P., Murphy, Alyssa, Majumder, Madhurima, de Blieck, Elisabeth A., Auinger, Peggy, Cudkowicz, Merit E., Atassi, Nazem
Publicado no J Huntingtons Dis (2017)

Pre-morbid Type 2 Diabetes Mellitus is not a prognostic factor in ALS

Por Paganoni, Sabrina, Hyman, Theodore, Shui, Amy, Allred, Peggy, Harms, Matthew, Liu, Jingxia, Maragakis, Nicholas, Schoenfeld, David, Yu, Hong, Atassi, Nazem, Cudkowicz, Merit, Miller, Timothy M.
Publicado no Muscle Nerve (2015)

Analysis of start-up, retention, and adherence in ALS clinical trials

Por Atassi, Nazem, Yerramilli-Rao, Padmaja, Szymonifka, Jackie, Yu, Hong, Kearney, Marianne, Grasso, Daniela, Deng, Jing, Levine-Weinberg, Mark, Shapiro, Jordan, Lee, Alexandra, Joseph, Lucia, Macklin, Eric A., Cudkowicz, Merit E.
Publicado em 2013

Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis

Por Atassi, Nazem, Xu, Maosheng, Triantafyllou, Christina, Keil, Boris, Lawson, Robert, Cernasov, Paul, Ratti, Elena, Long, Christopher J., Paganoni, Sabrina, Murphy, Alyssa, Salibi, Nouha, Seethamraju, Ravi, Rosen, Bruce, Ratai, Eva-Maria
Publicado no PLoS One (2017)

Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [(11)C]-PBR28

Por Zürcher, Nicole R., Loggia, Marco L., Lawson, Robert, Chonde, Daniel B., Izquierdo-Garcia, David, Yasek, Julia E., Akeju, Oluwaseun, Catana, Ciprian, Rosen, Bruce R., Cudkowicz, Merit E., Hooker, Jacob M., Atassi, Nazem
Publicado no Neuroimage Clin (2015)

Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability

Por Berry, James D., Paganoni, Sabrina, Atassi, Nazem, Macklin, Eric A., Goyal, Namita, Rivner, Michael, Simpson, Ericka, Appel, Stanley, Grasso, Daniela L., Mejia, Nicte I., Mateen, Farrah, Gill, Alan, Vieira, Fernando, Tassinari, Valerie, Perrin, Steven
Publicado no Muscle Nerve (2017)

Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis

Por Alshikho, Mohamad J., Zürcher, Nicole R., Loggia, Marco L., Cernasov, Paul, Chonde, Daniel B., Izquierdo Garcia, David, Yasek, Julia E., Akeju, Oluwaseun, Catana, Ciprian, Rosen, Bruce R., Cudkowicz, Merit E., Hooker, Jacob M., Atassi, Nazem
Publicado no Neurology (2016)

Pseudoreference Regions for Glial Imaging with (11)C-PBR28: Investigation in 2 Clinical Cohorts

Por Albrecht, Daniel S., Normandin, Marc D., Shcherbinin, Sergey, Wooten, Dustin W., Schwarz, Adam J., Zürcher, Nicole R., Barth, Vanessa N., Guehl, Nicolas J., Akeju, Oluwaseun, Atassi, Nazem, Veronese, Mattia, Turkheimer, Federico, Hooker, Jacob M., Loggia, Marco L.
Publicado no J Nucl Med (2018)

Imaging of glia activation in people with primary lateral sclerosis

Por Paganoni, Sabrina, Alshikho, Mohamad J., Zürcher, Nicole R., Cernasov, Paul, Babu, Suma, Loggia, Marco L., Chan, James, Chonde, Daniel B., Garcia, David Izquierdo, Catana, Ciprian, Mainero, Caterina, Rosen, Bruce R., Cudkowicz, Merit E., Hooker, Jacob M., Atassi, Nazem
Publicado no Neuroimage Clin (2017)